Cargando…
ACE2 level as a marker of CVD
Higher levels of angiotensin-converting enzyme 2 in plasma are associated with a greater risk of major cardiovascular disease events, according to a global, population-based study.
Autor principal: | Fernández-Ruiz, Irene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573518/ https://www.ncbi.nlm.nih.gov/pubmed/33082580 http://dx.doi.org/10.1038/s41569-020-00468-2 |
Ejemplares similares
-
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
por: Abd El-Aziz, Tarek Mohamed, et al.
Publicado: (2020) -
Outsmarting SARS-CoV-2 by empowering a decoy ACE2
por: Sokolowska, Milena
Publicado: (2020) -
Omicron: Master of immune evasion maintains robust ACE2 binding
por: Hoffmann, Markus, et al.
Publicado: (2022) -
A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2
por: Su, Shan, et al.
Publicado: (2020) -
SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2
por: Allison, Susan J.
Publicado: (2020)